General meeting

Annual General Meeting 2021

The Annual General Meeting will be held on the May 4, 2021 in Stockholm.

Shareholders who wish to have a matter addressed at a general meeting must submit a request in writing to the Board of Directors. The request should, under normal circumstances, reach the Board of Directors by no later than seven weeks before the meeting. However, any shareholder who submits a matter sufficiently in advance that the matter can be included in the notice to the general meeting is entitled to have the matter addressed at the general meeting. Shareholders who wish to have a matter addressed at the Annual General Meeting, please contact the Board of Directors of Immunicum via mail to: The Board of Directors, Immunicum AB (publ), Östermalmstorg 5, SE-114 42 Stockholm, Sweden, or e-mail: info@immunicum.com.

Extraordinary General Meeting in Immunicum AB (publ) 2021

The Extraordinary General Meeting will take place on January 22, 2021 at 13:00 at IVA’s Conference Center at Grev Turegatan 16 in Stockholm.

Immunicum cherish both its shareholders’ well-being as their opportunity to attend the Extraordinary General Meeting to exercise their rights as shareholders. In order to reduce the risk of spreading the covid-19, shareholders are offered the opportunity to vote through proxy at the general meeting or exercise their voting rights via mail before the general meeting. Please refer to the notice for further information regarding notification to the general meeting and for the opportunity to vote through proxy or via mail.

Shareholders who are ill or belong to a risk group should not participate, but are recommended to vote through proxy or via mail.

NOTIFICATION
Shareholders who wish to attend the meeting shall:
(i) be recorded in the share register maintained by Euroclear Sweden AB on the record date of Thursday, January 14, 2021, and

(ii) not later than on Monday, January 18, 2021 have notified their attendance and any advisors to the Company; either in writing via letter to Immunicum AB (publ), “General meeting”, Östermalmstorg 5, SE-114 42 Stockholm or by e-mail to info@immunicum.com.

Extraordinary General Meeting in Immunicum AB (publ) 2020

The Extraordinary General Meeting will take place on December 18, 2020 at 13:00 at IVA’s Conference Center at Grev Turegatan 16 in Stockholm.

Immunicum cherish both its shareholders’ well-being as their opportunity to attend the Extraordinary General Meeting to exercise their rights as shareholders. In order to reduce the risk of spreading the covid-19, shareholders are offered the opportunity to vote through proxy at the general meeting or exercise their voting rights via mail before the general meeting. Please refer to the notice for further information regarding notification to the general meeting and for the opportunity to vote through proxy or via mail.

Shareholders who are ill or belong to a risk group should not participate, but are recommended to vote through proxy or via mail.

NOTIFICATION
Shareholders who wish to attend the meeting shall:

1. be recorded in the share register maintained by Euroclear Sweden AB on the record date of Thursday, 10 December 2020, and

1. not later than on Monday, 14 December 2020 have notified their attendance and any advisors to the Company; either in writing via letter to Immunicum AB (publ), “General meeting”, Östermalmstorg 5, SE-114 42 Stockholm or by e-mail to info@immunicum.com.

Annual General Meeting 2020

The Annual General Meeting 2020 will take place on April 28, 2020 at 10:30 at the IVA Conference Center at Grev Turegatan 16, Stockholm.

Immunicum cherish both its shareholders’ well-being as their opportunity to the Annual General Meeting to exercise their rights as shareholders. In order to reduce the risk of spreading the virus covid-19 (the corona virus), Immuncium will hold a short and effective annual general meeting in order to limit the contacts between the participants.

As part of this, no food is served to the participants. Employees in the company who are ill or have been at risk will not be present in the premises.

Shareholders who are ill, have recently resided in a risk area or belong to a risk group should not participate, but are recommended to vote through a representative.

Annual General Meeting 2019

Extraordinary General Meeting 2018

Annual General Meeting 2018

Notice of annual general meeting and additional attachments are found below.

General meeting

In accordance with the Companies Act, is the shareholders’ influence in Immunicum exercised at the general meeting, which is the company’s highest ranking decision-making body. At the annual general meeting, the shareholders decide upon central matters, including amendments of the articles of association, confirmation of the income statements and balance sheets, possible dividends and distribution of the company’s profit or loss, election of board members and auditors and decisions regarding remuneration to the same, and decision regarding discharge of liability for the board of directors and the managing director.

In accordance with the articles of association, the notice of summons to annual general meeting shall be made by announcement in Post- och Inrikes Tidningar and by making the notice of summons available on the company’s website. Simultaneously with the notice, the company shall by way of announcement in Dagens Industri inform that notice has been made. Notice of summons to the annual general meeting and an extraordinary general meeting where a matter of amendment of the articles of association shall be resolved shall be made at earliest six (6) and not later than four (4) weeks prior the meeting. Notice of summons to other extraordinary general meetings shall be made at earliest six (6) and not later than three (3) weeks prior to the extraordinary general meeting.
Shareholders recorded in the share register in accordance with the provisions in the Companies Act, and that have given notice of their attendance to the company no later than the day mentioned in the notice, have the right to participate at the general meeting. Such day may not be on a Sunday, any other public holiday, Saturday, Midsummer Eve, Christmas Eve or New Year’s Eve and may not occur earlier than the fifth working day prior to the meeting.

At the annual general meeting, the following matters shall be addressed:

1. Election of chairman of the general meeting.

2. Preparation and approval of voting register.

3. Presentation and approval of the agenda.

4. Election of one or two persons to check the minutes.

5. Control if the meeting has been duly convened.

6. Presentation of the annual report and the audit report and, if applicable, the consolidated annual report and consolidated audit report.

7. Decisions
a) on confirmation of the income statement and balance sheet and, if applicable, the group income statement and group balance sheet.
b) on disposition of the company’s profit or loss according to the adopted balance sheet.
c) discharge of liability for the board of directors and the managing director.

8. Determination of remuneration for the directors of the board of directors and auditors.

9. Election of directors of the board of directors and auditors and, if applicable, deputy auditors.

10. Other matters that are to be addressed at the annual general meeting pursuant to the Companies Act or the articles of association.

Extraordinary General Meeting 2017

Notice of extraordinary general meeting and additional attachments are found below.

Annual General Meeting 2017